A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
- Autores
- Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; Zhang, Chengyue; Zhao, Junyang; Wilson, Matthew W.; Kim, Jonathan; Khetan, Vikas; Ganesan, Suganeswari; Yarovoy, Andrey; Yarovaya, Vera; Kotova, Elena; Yousef, Yacoub A.; Nummi, Kalle; Ushakova, Tatiana L.; Yugay, Olga V.; Polyakov, Vladimir G.; Ramirez Ortiz, Marco A.; Esparza Aguiar, Elizabeth; Chantada, Guillermo Luis; Schaiquevich, Paula Susana; Fandino, Adriana; Yam, Jason C.; Lau, Winnie W.; Lam, Carol P.; Sharwood, Phillipa; Moorthy, Sonia; Long, Quah Boon
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.
Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados Unidos
Fil: Finger, Paul T.. The New York Eye Cancer Center; Estados Unidos
Fil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; Canadá
Fil: Mallipatna, Ashwin. Hospital for Sick Children; Canadá
Fil: Kivelä, Tero T.. Helsinki University Hospital; Finlandia
Fil: Zhang, Chengyue. Beijing Children's Hospital; China
Fil: Zhao, Junyang. Beijing Children's Hospital; China
Fil: Wilson, Matthew W.. University of Tennessee; Estados Unidos
Fil: Kim, Jonathan. University of Southern California; Estados Unidos
Fil: Khetan, Vikas. Sankara Nethralaya; India
Fil: Ganesan, Suganeswari. Sankara Nethralaya; India
Fil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; Rusia
Fil: Yousef, Yacoub A.. King Hussein Cancer Center; Jordania
Fil: Nummi, Kalle. University of Helsinki; Finlandia
Fil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia
Fil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; México
Fil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; México
Fil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
Fil: Yam, Jason C.. The Chinese University of Hong Kong; Hong Kong
Fil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong Kong
Fil: Lam, Carol P.. The Chinese University of Hong Kong; Hong Kong
Fil: Sharwood, Phillipa. University of Sydney; Australia
Fil: Moorthy, Sonia. KK Women's and Children's Hospital; Singapur
Fil: Long, Quah Boon. KK Women's and Children's Hospital; Singapur - Materia
-
RETINOBLASTOMA
METASTASIS
STAGING SYSTEM
TNM - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/156304
Ver los metadatos del registro completo
id |
CONICETDig_700c0838eb44f1b906395f3f7667f349 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/156304 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated MortalityTomar, Ankit SinghFinger, Paul T.Gallie, BrendaMallipatna, AshwinKivelä, Tero T.Zhang, ChengyueZhao, JunyangWilson, Matthew W.Kim, JonathanKhetan, VikasGanesan, SuganeswariYarovoy, AndreyYarovaya, VeraKotova, ElenaYousef, Yacoub A.Nummi, KalleUshakova, Tatiana L.Yugay, Olga V.Polyakov, Vladimir G.Ramirez Ortiz, Marco A.Esparza Aguiar, ElizabethChantada, Guillermo LuisSchaiquevich, Paula SusanaFandino, AdrianaYam, Jason C.Lau, Winnie W.Lam, Carol P.Sharwood, PhillipaMoorthy, SoniaLong, Quah BoonRETINOBLASTOMAMETASTASISSTAGING SYSTEMTNMhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB.Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados UnidosFil: Finger, Paul T.. The New York Eye Cancer Center; Estados UnidosFil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; CanadáFil: Mallipatna, Ashwin. Hospital for Sick Children; CanadáFil: Kivelä, Tero T.. Helsinki University Hospital; FinlandiaFil: Zhang, Chengyue. Beijing Children's Hospital; ChinaFil: Zhao, Junyang. Beijing Children's Hospital; ChinaFil: Wilson, Matthew W.. University of Tennessee; Estados UnidosFil: Kim, Jonathan. University of Southern California; Estados UnidosFil: Khetan, Vikas. Sankara Nethralaya; IndiaFil: Ganesan, Suganeswari. Sankara Nethralaya; IndiaFil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; RusiaFil: Yousef, Yacoub A.. King Hussein Cancer Center; JordaniaFil: Nummi, Kalle. University of Helsinki; FinlandiaFil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; RusiaFil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; MéxicoFil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; MéxicoFil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; ArgentinaFil: Yam, Jason C.. The Chinese University of Hong Kong; Hong KongFil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong KongFil: Lam, Carol P.. The Chinese University of Hong Kong; Hong KongFil: Sharwood, Phillipa. University of Sydney; AustraliaFil: Moorthy, Sonia. KK Women's and Children's Hospital; SingapurFil: Long, Quah Boon. KK Women's and Children's Hospital; SingapurElsevier Science Inc.2020-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/156304Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-17320161-64201549-4713CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.aaojournal.org/article/S0161-6420(20)30516-9/fulltextinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2020.05.050info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:16:40Zoai:ri.conicet.gov.ar:11336/156304instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:16:41.236CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
title |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
spellingShingle |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality Tomar, Ankit Singh RETINOBLASTOMA METASTASIS STAGING SYSTEM TNM |
title_short |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
title_full |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
title_fullStr |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
title_full_unstemmed |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
title_sort |
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality |
dc.creator.none.fl_str_mv |
Tomar, Ankit Singh Finger, Paul T. Gallie, Brenda Mallipatna, Ashwin Kivelä, Tero T. Zhang, Chengyue Zhao, Junyang Wilson, Matthew W. Kim, Jonathan Khetan, Vikas Ganesan, Suganeswari Yarovoy, Andrey Yarovaya, Vera Kotova, Elena Yousef, Yacoub A. Nummi, Kalle Ushakova, Tatiana L. Yugay, Olga V. Polyakov, Vladimir G. Ramirez Ortiz, Marco A. Esparza Aguiar, Elizabeth Chantada, Guillermo Luis Schaiquevich, Paula Susana Fandino, Adriana Yam, Jason C. Lau, Winnie W. Lam, Carol P. Sharwood, Phillipa Moorthy, Sonia Long, Quah Boon |
author |
Tomar, Ankit Singh |
author_facet |
Tomar, Ankit Singh Finger, Paul T. Gallie, Brenda Mallipatna, Ashwin Kivelä, Tero T. Zhang, Chengyue Zhao, Junyang Wilson, Matthew W. Kim, Jonathan Khetan, Vikas Ganesan, Suganeswari Yarovoy, Andrey Yarovaya, Vera Kotova, Elena Yousef, Yacoub A. Nummi, Kalle Ushakova, Tatiana L. Yugay, Olga V. Polyakov, Vladimir G. Ramirez Ortiz, Marco A. Esparza Aguiar, Elizabeth Chantada, Guillermo Luis Schaiquevich, Paula Susana Fandino, Adriana Yam, Jason C. Lau, Winnie W. Lam, Carol P. Sharwood, Phillipa Moorthy, Sonia Long, Quah Boon |
author_role |
author |
author2 |
Finger, Paul T. Gallie, Brenda Mallipatna, Ashwin Kivelä, Tero T. Zhang, Chengyue Zhao, Junyang Wilson, Matthew W. Kim, Jonathan Khetan, Vikas Ganesan, Suganeswari Yarovoy, Andrey Yarovaya, Vera Kotova, Elena Yousef, Yacoub A. Nummi, Kalle Ushakova, Tatiana L. Yugay, Olga V. Polyakov, Vladimir G. Ramirez Ortiz, Marco A. Esparza Aguiar, Elizabeth Chantada, Guillermo Luis Schaiquevich, Paula Susana Fandino, Adriana Yam, Jason C. Lau, Winnie W. Lam, Carol P. Sharwood, Phillipa Moorthy, Sonia Long, Quah Boon |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
RETINOBLASTOMA METASTASIS STAGING SYSTEM TNM |
topic |
RETINOBLASTOMA METASTASIS STAGING SYSTEM TNM |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB. Fil: Tomar, Ankit Singh. The New York Eye Cancer Center; Estados Unidos Fil: Finger, Paul T.. The New York Eye Cancer Center; Estados Unidos Fil: Gallie, Brenda. The Eye Cancer Clinic, Princess Margaret Cancer Centre; Canadá Fil: Mallipatna, Ashwin. Hospital for Sick Children; Canadá Fil: Kivelä, Tero T.. Helsinki University Hospital; Finlandia Fil: Zhang, Chengyue. Beijing Children's Hospital; China Fil: Zhao, Junyang. Beijing Children's Hospital; China Fil: Wilson, Matthew W.. University of Tennessee; Estados Unidos Fil: Kim, Jonathan. University of Southern California; Estados Unidos Fil: Khetan, Vikas. Sankara Nethralaya; India Fil: Ganesan, Suganeswari. Sankara Nethralaya; India Fil: Yarovoy, Andrey. Fyodorov Eye Microsurgery Federal State Institution; Rusia Fil: Yarovaya, Vera. Fyodorov Eye Microsurgery Federal State Institution; Rusia Fil: Kotova, Elena. Fyodorov Eye Microsurgery Federal State Institution; Rusia Fil: Yousef, Yacoub A.. King Hussein Cancer Center; Jordania Fil: Nummi, Kalle. University of Helsinki; Finlandia Fil: Ushakova, Tatiana L.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia Fil: Yugay, Olga V.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia Fil: Polyakov, Vladimir G.. Blokhin National Medical Research Center Oncology of Russian Federation; Rusia Fil: Ramirez Ortiz, Marco A.. Hospital Infantil de México Federico Gómez; México Fil: Esparza Aguiar, Elizabeth. Hospital Infantil de México Federico Gómez; México Fil: Chantada, Guillermo Luis. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Schaiquevich, Paula Susana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Fandino, Adriana. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina Fil: Yam, Jason C.. The Chinese University of Hong Kong; Hong Kong Fil: Lau, Winnie W.. The Chinese University of Hong Kong; Hong Kong Fil: Lam, Carol P.. The Chinese University of Hong Kong; Hong Kong Fil: Sharwood, Phillipa. University of Sydney; Australia Fil: Moorthy, Sonia. KK Women's and Children's Hospital; Singapur Fil: Long, Quah Boon. KK Women's and Children's Hospital; Singapur |
description |
Purpose: To evaluate the ability of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to estimate metastatic and mortality rates for children with retinoblastoma (RB). Design: International, multicenter, registry-based retrospective case series. Participants: A total of 2190 patients from 18 ophthalmic oncology centers from 13 countries over 6 continents. Methods: Patient-specific data fields for RB were designed and selected by subcommittee. All patients with RB with adequate records to allow tumor staging by the AJCC criteria and follow-up for metastatic disease were studied. Main Outcome Measures: Metastasis-related 5- and 10-year survival data after initial tumor staging were estimated with the KaplaneMeier method depending on AJCC clinical (cTNM) and pathological (pTNM) tumor, node, metastasis category and age, tumor laterality, and presence of heritable trait. Results: Of 2190 patients, the records of 2085 patients (95.2%) with 2905 eyes were complete. The median age at diagnosis was 17.0 months. A total of 1260 patients (65.4%) had unilateral RB. Among the 2085 patients, tumor categories were cT1a in 55 (2.6%), cT1b in 168 (8.1%), cT2a in 197 (9.4%), cT2b in 812 (38.9%), cT3 in 835 (40.0%), and cT4 in 18 (0.9%). Of these, 1397 eyes in 1353 patients (48.1%) were treated with enucleation. A total of 109 patients (5.2%) developed metastases and died. The median time (n ¼ 92) from diagnosis to metastasis was 9.50 months. The 5-year KaplaneMeier cumulative survival estimates by clinical tumor categories were 100% for category cT1a, 98% (95% confidence interval [CI], 97e99) for cT1b and cT2a, 96% (95% CI, 95e97) for cT2b, 89% (95% CI, 88e90) for cT3 tumors, and 45% (95% CI, 31e59) for cT4 tumors. Risk of metastasis increased with increasing cT (and pT) category (P < 0.001). Cox proportional hazards regression analysis confirmed a higher risk of metastasis in category cT3 (hazard rate [HR], 8.09; 95% CI, 2.55e25.70; P < 0.001) and cT4 (HR, 48.55; 95% CI, 12.86e183.27; P < 0.001) compared with category cT1. Age, tumor laterality, and presence of heritable traits did not influence the incidence of metastatic disease. Conclusions: Multicenter, international, internet-based data sharing facilitated analysis of the 8th edition AJCC RB Staging System for metastasis-related mortality and offered a proof of concept yielding quantitative, predictive estimates per category in a large, real-life, heterogeneous patient population with RB. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/156304 Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-1732 0161-6420 1549-4713 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/156304 |
identifier_str_mv |
Tomar, Ankit Singh; Finger, Paul T.; Gallie, Brenda; Mallipatna, Ashwin; Kivelä, Tero T.; et al.; A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality; Elsevier Science Inc.; Ophthalmology; 127; 12; 6-2020; 1719-1732 0161-6420 1549-4713 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.aaojournal.org/article/S0161-6420(20)30516-9/fulltext info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ophtha.2020.05.050 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier Science Inc. |
publisher.none.fl_str_mv |
Elsevier Science Inc. |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614113656832000 |
score |
13.070432 |